Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04508140
Status:
TERMINATED
Last Update Posted:
2022-12-13
First Post:
2020-08-05
Brief Title:
Study of BO-112 With Pembrolizumab for Colorectal or GastricGEJ Cancer With Liver Metastasis
Sponsor:
Highlight Therapeutics
Organization:
Highlight Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-05
First Submit QC Date:
August 10 2020
Study First Post Date:
2020-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-09
Last Update Post Date:
2022-12-13
Last Update Post Date Type:
ACTUAL